Results of Phase III Randomized Trial for Use of Docetaxel as a Radiosensitizer in Patients With Head and Neck Cancer, Unsuitable for Cisplatin-Based Chemoradiation.
51
mentions
- X 32
- News 14
- Blogs 3
- YouTube 2
PubHawk tracks social media discussions for 1 article by authors named Vijayalakshmi Mathrudev.
Mentions
Extended reach
Total likes
Video views
Tracked by PubHawk
From PubMed
Searching PubMed…